• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将 microRNAs 有效递送至成人人心肌成纤维细胞的脂质体,用于前瞻性的直接心脏细胞重编程。

Lipoplexes for effective in vitro delivery of microRNAs to adult human cardiac fibroblasts for perspective direct cardiac cell reprogramming.

机构信息

Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy.

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria, 11, 10125, Turin, Italy.

出版信息

Nanomedicine. 2022 Sep;45:102589. doi: 10.1016/j.nano.2022.102589. Epub 2022 Jul 28.

DOI:10.1016/j.nano.2022.102589
PMID:35908737
Abstract

Design of nanocarriers for efficient miRNA delivery can significantly improve miRNA-based therapies. Lipoplexes based on helper lipid, dioleoyl phosphatidylethanolamine (DOPE) and cationic lipid [2-(2,3-didodecyloxypropyl)-hydroxyethyl] ammonium bromide (DE) were formulated to efficiently deliver miR-1 or a combination of four microRNAs (miRcombo) to adult human cardiac fibroblasts (AHCFs). Lipoplexes with amino-to-phosphate groups ratio of 3 (N/P 3) showed nanometric hydrodynamic size (372 nm), positive Z-potential (40 mV) and high stability under storage conditions. Compared to commercial DharmaFECT1 (DF), DE-DOPE/miRNA lipoplexes showed superior miRNA loading efficiency (99 % vs. 64 %), and faster miRNA release (99 % vs. 82 % at 48 h). DE-DOPE/miR-1 lipoplexes showed superior viability (80-100 % vs. 50 %) in AHCFs, a 2-fold higher miR-1 expression and Twinfilin-1 (TWF-1) mRNA downregulation. DE-DOPE/miRcombo lipoplexes significantly enhanced AHCFs reprogramming into induced cardiomyocytes (iCMs), as shown by increased expression of CM markers compared to DF/miRcombo.

摘要

纳米载体的设计可有效提高 miRNA 的传递效率,从而显著改善 miRNA 疗法。本文构建了基于辅助脂质二油酰基磷脂酰乙醇胺(DOPE)和阳离子脂质[2-(2,3-二二十二烷氧基丙基)-羟乙基]溴化铵(DE)的阳离子脂质体,用于有效递送至成年人心房成纤维细胞(AHCFs)的 miR-1 或四种 microRNA 混合物(miRcombo)。具有氨基与磷酸基团比例为 3(N/P 3)的阳离子脂质体具有纳米级流体力学粒径(372nm)、正 zeta 电位(40mV),且在储存条件下具有高稳定性。与商业试剂 DharmaFECT1(DF)相比,DE-DOPE/miRNA 脂质体表现出更高的 miRNA 负载效率(99%对 64%)和更快的 miRNA 释放(48h 时 99%对 82%)。DE-DOPE/miR-1 脂质体在 AHCFs 中表现出更好的细胞活力(80-100%对 50%),miR-1 表达更高,Twinfilin-1(TWF-1)mRNA 下调 2 倍。与 DF/miRcombo 相比,DE-DOPE/miRcombo 脂质体显著增强了 AHCFs 向诱导型心肌细胞(iCM)的重编程,表现为 CM 标志物表达增加。

相似文献

1
Lipoplexes for effective in vitro delivery of microRNAs to adult human cardiac fibroblasts for perspective direct cardiac cell reprogramming.用于将 microRNAs 有效递送至成人人心肌成纤维细胞的脂质体,用于前瞻性的直接心脏细胞重编程。
Nanomedicine. 2022 Sep;45:102589. doi: 10.1016/j.nano.2022.102589. Epub 2022 Jul 28.
2
MicroRNA-Mediated Direct Reprogramming of Human Adult Fibroblasts Toward Cardiac Phenotype.微小RNA介导的人类成纤维细胞向心脏表型的直接重编程
Front Bioeng Biotechnol. 2020 Jun 5;8:529. doi: 10.3389/fbioe.2020.00529. eCollection 2020.
3
Direct Reprogramming of Adult Human Cardiac Fibroblasts into Induced Cardiomyocytes Using miRcombo.利用 miRcombo 将成人心脏成纤维细胞直接重编程为诱导性心肌细胞。
Methods Mol Biol. 2022;2573:31-40. doi: 10.1007/978-1-0716-2707-5_3.
4
Cardiac Tissue-like 3D Microenvironment Enhances Route towards Human Fibroblast Direct Reprogramming into Induced Cardiomyocytes by microRNAs.心脏组织样 3D 微环境通过 microRNAs 增强人成纤维细胞直接重编程为诱导性心肌细胞的途径。
Cells. 2022 Feb 25;11(5):800. doi: 10.3390/cells11050800.
5
In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids.体外阳离子脂质介导的基因递送与氟化甘油磷酸乙醇胺辅助脂质。
Bioconjug Chem. 2001 Nov-Dec;12(6):949-63. doi: 10.1021/bc010033j.
6
Influence of Lipid Composition of Cationic Liposomes 2X3-DOPE on mRNA Delivery into Eukaryotic Cells.阳离子脂质体2X3-DOPE的脂质组成对mRNA导入真核细胞的影响。
Pharmaceutics. 2022 Dec 20;15(1):8. doi: 10.3390/pharmaceutics15010008.
7
Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.在高血清条件下,具有羟乙基取代基头基的α-生育酚化阳离子双子脂质的转染效率。
Org Biomol Chem. 2018 Mar 14;16(11):1983-1993. doi: 10.1039/c7ob02835k.
8
siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.通过阳离子脂质体全身注射将小干扰RNA递送至肺转移瘤。
J Liposome Res. 2015;25(4):279-86. doi: 10.3109/08982104.2014.992024. Epub 2015 Sep 4.
9
Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.靶向CD44透明质酸受体的脂质体复合物用于乳腺癌细胞的高效转染
Mol Pharm. 2009 Jul-Aug;6(4):1062-73. doi: 10.1021/mp800215d.
10
Exploitation of De Novo helper-lipids for effective gene delivery.利用新型辅助脂质实现有效的基因递送。
J Pharm Pharm Sci. 2008;11(4):56-67. doi: 10.18433/j31s3b.

引用本文的文献

1
Design and Validation of Hybrid Polymer-Lipid Nanoparticles as Novel Transfection Vectors for MicroRNA Delivery to Human Cardiac Fibroblasts.用于将微小RNA递送至人心脏成纤维细胞的新型转染载体——混合聚合物-脂质纳米颗粒的设计与验证
Adv Healthc Mater. 2025 Jul;14(18):e2500971. doi: 10.1002/adhm.202500971. Epub 2025 Jun 6.
2
European Research Council-funded grant: development of a novel cardiac tissue model.欧洲研究理事会资助项目:新型心脏组织模型的开发
Eur Heart J. 2025 Jan 16;46(3):233-235. doi: 10.1093/eurheartj/ehae740.
3
3D bioartificial stretchable scaffolds mimicking the mechanical hallmarks of human cardiac fibrotic tissue.
模仿人类心脏纤维化组织力学特征的3D生物人工可拉伸支架。
Int J Bioprint. 2024 May 15;10(3):2247. doi: 10.36922/ijb.2247.
4
Modifying miRs for effective reprogramming of fibroblasts to cardiomyocytes.修饰微小RNA以实现成纤维细胞向心肌细胞的有效重编程。
Mol Ther Nucleic Acids. 2024 Feb 28;35(2):102160. doi: 10.1016/j.omtn.2024.102160. eCollection 2024 Jun 11.
5
Fibroblast Reprogramming in Cardiac Repair.心脏修复中的成纤维细胞重编程
JACC Basic Transl Sci. 2023 Sep 20;9(1):145-160. doi: 10.1016/j.jacbts.2023.06.012. eCollection 2024 Jan.
6
In Vitro Mechanical Stimulation to Reproduce the Pathological Hallmarks of Human Cardiac Fibrosis on a Beating Chip and Predict The Efficacy of Drugs and Advanced Therapies.体外机械刺激以在跳动芯片上重现人类心脏纤维化的病理特征并预测药物和先进疗法的疗效。
Adv Healthc Mater. 2024 Feb;13(4):e2301481. doi: 10.1002/adhm.202301481. Epub 2023 Nov 27.
7
Can we stop one heart from breaking: triumphs and challenges in cardiac reprogramming.能否阻止心脏破裂:心脏重编程的成功与挑战。
Curr Opin Genet Dev. 2023 Dec;83:102116. doi: 10.1016/j.gde.2023.102116. Epub 2023 Oct 3.
8
Cardiac microRNAs: diagnostic and therapeutic potential.心脏微小RNA:诊断和治疗潜力
Arch Med Sci. 2023 Aug 25;19(5):1360-1381. doi: 10.5114/aoms/169775. eCollection 2023.
9
Biomimetic Electrospun Scaffold-Based In Vitro Model Resembling the Hallmarks of Human Myocardial Fibrotic Tissue.基于仿生电纺支架的体外模型模拟人类心肌纤维化组织的特征。
ACS Biomater Sci Eng. 2023 Jul 10;9(7):4368-4380. doi: 10.1021/acsbiomaterials.3c00483. Epub 2023 Jun 8.
10
Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration.常驻非心肌细胞的直接重编程及其在体内心脏再生中的潜力。
Cells. 2023 Apr 15;12(8):1166. doi: 10.3390/cells12081166.